Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.01 B1.07 B1.08 B1.25 B 4.41 B Research & development 251.2 M257.8 M253.9 M265.9 M 1.03 B Operating income -1.14 B-1.12 B-922.4 M-1.33 B -4.51 B Non-Operating Income, Total 110.1 M105.8 M75 M119.7 M 410.6 M Interest expense, net of interest capitalized 135.4 M124.1 M78.7 M121.1 M 459.3 M Non-Operating Income, excl. Interest Expenses -25.3 M-18.3 M-3.7 M-1.4 M -48.7 M Unusual income/expense ———— — Pretax income 1.31 B1.38 B1.78 B1.26 B 5.73 B Equity in earnings ———— — Taxes 294.5 M321.2 M422 M279.1 M 1.32 B Non-controlling/minority interest ———— — After tax other income/expense -2.5 M-1.7 M-800 K800 K -4.2 M Net income before discontinued operations 1.01 B1.06 B1.36 B978.7 M 4.41 B Discontinued operations ———— — Net income 1.01 B1.06 B1.36 B978.7 M 4.41 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 1.01 B1.06 B1.36 B978.7 M 4.41 B Basic earnings per share (Basic EPS) 2.52.633.392.45 10.97 Diluted earnings per share (Diluted EPS) 2.492.623.382.45 10.94 Average basic shares outstanding 405.1 M403.8 M401.7 M402.3 M — Diluted shares outstanding 406.5 M404.7 M402.5 M403.3 M — EBITDA 1.34 B1.42 B1.85 B1.29 B 5.91 B EBIT 1.2 B1.28 B1.71 B1.14 B 5.32 B Cost of revenue 2.84 B2.89 B3.07 B2.96 B 11.76 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 146.7 M145.6 M146.4 M147.2 M 585.9 M